Tepezza, a medication approved by the FDA to treat thyroid eye disease (TED), has become the center of several Tepezza lawsuits in Nebraska and other states. Patients who have experienced permanent hearing loss and tinnitus after taking the drug are filing lawsuits against Horizon Therapeutics, the manufacturer of Tepezza.
If you or someone you care about has experienced complications related to Tepezza, such as hearing loss, the committed team at Schmidt & Clark, LLP is ready to assist. As a national law firm specializing in cases for plaintiffs, our foremost goal is to ensure that you obtain the justice and rightful compensation you deserve.
Table Of Contents
- Nebraska Tepezza Lawsuits
- What Is Tepezza?
- Does Tepezza Cause Hearing Problems?
- Potential Settlements and Compensation in Nebraska Tepezza Lawsuits
- Who Qualifies to File a Nebraska Tepezza Lawsuit?
- Filing a Nebraska Tepezza Hearing Loss Lawsuit
- FAQs
- Get Your Free Case Evaluation From Nebraska Tepezza Lawyers
Nebraska Tepezza Lawsuits
A growing number of lawsuits have been filed against Horizon Therapeutics, alleging that the company failed to adequately warn patients and healthcare providers about the risk of permanent hearing loss and tinnitus associated with Tepezza. These lawsuits argue that Horizon should have been aware of the potential hearing-related side effects but did not provide sufficient information to users and providers about the risks.
The legal landscape surrounding filing Tepezza lawsuits is complex and evolving, with individual Tepezza lawsuit claims being filed in various states and a class-action lawsuit filed in Nebraska. Should you have suffered hearing loss or tinnitus from Tepezza, you might qualify to initiate a lawsuit and pursue compensation for your damages.
Plaintiffs’ Claims and Horizon’s Defense
The crux of the plaintiffs’ claims in the Tepezza lawsuits is that Horizon failed to provide adequate warnings about the risk of permanent hearing damage associated with the drug. They maintain that Horizon neither advised doctors to supervise their patients’ hearing nor did it carry out adequate tests prior to securing FDA approval.
These plaintiffs also claim that Horizon misrepresented the benefits of Tepezza, leading more people to believe they would benefit from the drug than they actually do.
In response to these allegations, Horizon has denied the claims and asserted the safety of Tepezza. The company argues that the FDA’s approval of the drug and the updated warning labels demonstrate its commitment to patient safety. However, recent studies have shown a significant percentage of Tepezza patients experience hearing-related side effects, adding weight to the plaintiffs’ claims.
Recent Developments in Tepezza Litigation
The Tepezza hearing loss lawsuits have been consolidated into multidistrict litigation (MDL) in the Northern District of Illinois, with over 50 pending cases. MDL is a legal process that combines multiple mass tort lawsuits, allowing for more efficient pre-trial proceedings against the same defendant or group of defendants. The goal of this consolidation is to simplify the legal proceedings and enhance the chances of a reasonable resolution for all involved parties.
As the number of cases in the Tepezza MDL continues to grow, Magistrate Judge M. David Weisman is managing the discovery process and overseeing the settlement conference.
With more than 50 ongoing cases and new developments emerging, the outcome of the Nebraska Tepezza lawsuits remains uncertain. Still, the consolidation of these cases may pave the way for potential settlements and compensation for those affected by hearing loss and tinnitus caused by the drug.
What Is Tepezza?
Tepezza is an FDA-approved medication designed for Graves disease, also known as treat thyroid eye disease (TED), a rare autoimmune condition that causes swelling and damage to the tissues surrounding the eyes [1]. The drug is administered intravenously over three to six months, providing relief for patients suffering from bulging eyes, double vision, and eye discomfort associated with TED.
However, post-approval, some patients have reported hearing loss and tinnitus associated with Tepezza. The FDA has updated the drug’s warning labels to indicate that Tepezza can cause permanent hearing impairment or loss, highlighting the need for increased awareness and monitoring of this potential side effect.
Tepezza Side Effects & Hearing Loss
Several studies have found that a significant percentage of Tepezza patients experience hearing-related side effects. These studies imply that despite Tepezza’s effectiveness in treating TED, it poses a risk of hearing loss and tinnitus to a significant number of patients.
The exact cause of Tepezza-related hearing loss remains unclear. Still, the high incidence of hearing issues among patients taking the drug has led to increased scrutiny and calls for better monitoring and awareness of this potential side effect. If you, or someone you know, have encountered hearing loss or tinnitus after using Tepezza, consulting with a seasoned attorney to assess your legal recourse is highly recommended.
Does Tepezza Cause Hearing Problems?
Tepezza does cause hearing problems. Research suggests that Tepezza may cause hearing problems in some patients. A study published in 2022 found that more than 80% of patients reported hearing loss and tinnitus after receiving Tepezza infusions [2]. These findings highlight the potential risk of hearing problems associated with Tepezza treatment.
Up to 65% of Tepezza users experienced hearing damage after taking the drug for their thyroid eye disease treatment. – The Endocrine Society
Though the precise cause of hearing loss related to Tepezza remains a mystery, the mounting evidence connecting the drug to auditory problems emphasizes the necessity for patients and healthcare providers to be attentive in monitoring and addressing any hearing-related side effects.
If you have had sensorineural hearing loss or tinnitus after using Tepezza, seeking legal counsel and contemplating a Tepezza class action lawsuit against Horizon Therapeutics is of utmost importance.
Potential Settlements and Compensation in Nebraska Tepezza Lawsuits
Settlement amounts for Tepezza hearing loss lawsuits may vary depending on factors such as the severity of the injury and the strength of the case. Compensation could range from $140,000 to $350,000, providing relief for medical expenses, lost wages, and pain and suffering caused by the side effects of the drug.
In light of the Tepezza lawsuit settlement, affected individuals must seek legal advice to ensure they receive the compensation they deserve.
While no two cases are the same, and the outcome of each lawsuit may differ, having an experienced attorney by your side can significantly improve your chances of obtaining a fair settlement. If you have endured hearing loss or tinnitus following the use of Tepezza, it is integral to investigate your legal possibilities and pursue the compensation you are entitled to.
Who Qualifies to File a Nebraska Tepezza Lawsuit?
Individuals who have taken Tepezza and experienced hearing loss or tinnitus qualify to file a Nebraska Tepezza lawsuit against Horizon Therapeutics. Suppose you have been diagnosed with thyroid eye disease and treated with Tepezza. In that case, it’s crucial to be proactive about assessing your hearing and seeking legal advice if you have experienced any hearing-related side effects.
Eligibility to file a lawsuit depends on factors such as the severity of the hearing loss, the timeline of events, and the strength of the evidence linking the side effects to Tepezza. Consulting with an experienced attorney can help determine if you qualify for a Tepezza hearing loss lawsuit and guide you through the legal process.
Filing a Nebraska Tepezza Hearing Loss Lawsuit
To file a Tepezza lawsuit in Nebraska, especially a Tepezza hearing loss lawsuit, consulting with a seasoned attorney who can assist in collecting evidence, constructing a robust case, and steering through the legal procedure is crucial. A personal injury lawyer can take care of everything for you, from filing the lawsuit to negotiating a settlement or fighting the case in court.
An attorney can help with your Tepezza lawsuit by:
- Gathering medical records and other evidence to support your case
- Demonstrating that you took the medication and ruling out other potential causes of hearing loss
- Working with a skilled legal team to improve your chances of obtaining a fair settlement and the compensation you deserve for your injuries.
FAQs
Is there a time limit for filing a Tepezza lawsuit in Nebraska?
Yes, statutes of limitations apply and vary by state. In Nebraska, it’s important to consult with a lawyer promptly to avoid missing the deadline.
What should I do if I experience side effects from Tepezza?
Seek immediate medical attention and consult a healthcare professional. Document your symptoms and consider consulting a lawyer to discuss your legal options.
Are there any class-action lawsuits for Tepezza?
Yes, there may be ongoing class-action lawsuits that consolidate individual claims to streamline the legal process and increase the chances of a favorable outcome.
Can I join a Tepezza lawsuit if I used it years ago?
Yes, you may still be eligible to file a lawsuit depending on the statute of limitations and your diagnosis timeline. Consult a lawyer to evaluate your case.
See all related dangerous drug lawsuits our attorneys covered so far.
Get Your Free Case Evaluation From Nebraska Tepezza Lawyers
At Schmidt and Clark, LLP we stand by your side when you need it most. If you or a family member has faced challenges related to Tepezza, don’t hesitate to get in touch. Our experienced team is well-versed in handling such cases, providing support throughout the entire process.
We ensure you’re informed about your legal rights and the potential for a lawsuit. Our consultations come at no cost to you, and you won’t have any financial obligations unless we secure a favorable outcome for your case.
Reference:
- https://www.tepezza.com/
- https://www.researchgate.net/publication/358870316_Hearing_Dysfunction_After_Treatment_With_Teprotumumab_for_Thyroid_Eye_Disease